Neuropharmacolgy Flashcards

1
Q

Bethanechol (Urecholine) mechanism of action

A

binds to muscarinic cholinergic receptors to relax trigone and sphincter muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bethanechol (Urecholine) adverse effects

A

hypotension, bradycardia, “see, pee, spit, shit”, N/V/D, increased respiratory secretions and bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bethanechol (Urecholine) nursing considerations

A

administer on an empty stomach to prevent N/V
assess for gastric obstruction if being used for GI motility issues
monitor for response
admin atropine if OD is suspected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pilocarpine mechanism of action

A

binds to muscarinic cholinergic receptors to reduce intraocular pressure and excessive xerostomia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pilocarpine adverse effects

A

miosis and blurred vision
sweating
hypotentsion and bradycardia
“see, pee, spit, shit”
syncope, HA, seizure, sweating
inc. respiratory secretions and bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pilocarpine nursing considerations

A

apply lacrimal pressure for 1-2 minutes post-administration
separate from other opthalamic medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pilocarpine patient education

A

dangers of driving at night and other hazardous occupations with poor illumination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Atropine (AtroPen) mechanism of action

A

block action of acetylcholine at muscarinic receptors to prevent effects of acetylcholine (primarily heart, exocrine glands, smooth muscles, and eyes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Atropine (AtroPen) adverse effects

A

anticholinergic effects (can’t see, can’t pee, can’t spit, can’t sit)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Atropine (AtroPen) nursing considerations

A

treat OD with symptomatic and supportive therapy
if delirium, hallucinations, or coma occurs administer physostigmine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Oxybutynin (Ditropan XL) mechanism of action

A

block activation of M3 receptors on the detrusor muscle to cause muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Oxybutynin (Ditropan XL) adverse effects

A

anticholinergic effects (can’t see, pee, spit, shit)
older adults have higher risk of hallucinations, confusion, and sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Oxybutynin (Ditropan XL) nursing considerations

A

concurrent use with other anticholinergic medications can intensify effects,
monitor mental status closely in older adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mirabegron (Myrbetriq) mechanism of action

A

activates beta-3 receptor to cause detrusor muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mirabegron (Myrbetriq) adverse effects

A

angioedema,
dose-related CV effects (HTN, tachycardia, and palpitations),
urinary retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pyridostigmine (Mestinon) mechanism of action

A

prevent breakdown of ACh by AChE via binding to increase amount of ACh available to activate receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pyridostigmine (Mestinon) adverse effects

A

Excessive muscarinic stimulation: SLUDGE, Killer B’s
neuromuscular blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pyridostigmine (Mestinon) nursing considerations

A

promote compliance,
assess ability to take PO meds prior to admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Donepezil (Aricept) mechanism of action

A

prevents reversible breakdown to ACh by AChE to increase availability of ACh at cholinergic synapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Donepezil (Aricept) adverse effects

A

GI effects - N/V/D and dyspepsia
CV effects - symptomatic bradycardia, prolonged QT waves, Torsades de pointes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Donepezil (Aricept) nursing considerations

A

place patient on fall precautions
monitor CV status and report symptomatic bradycardia and telemetry changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Donepezil (Aricept) patient education

A

education on patient and family role in condition management
(this medication is used for AD treatment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Rivastigmine (Exelon) mechanism of action

A

prevents irreversible breakdown of ACh by AChE to increase availability of ACh at cholinergic synapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Rivastigmine (Exelon) adverse effects

A

GI effects- N/V/D and dyspepsia
CV effects- symptomatic bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Rivastigmine (Exelon) nursing considerations

A

place pt on fall precautions
monitor CV status closely and report symptomatic bradycardia
change patch every 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Rivastigmine (Exelon) patient education

A

educate pt and family on role in condition management
(this med is used for treatment of AD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Memantine (Namenda) mechanism of action

A

modulates the effects of glutamate at NMDA receptors by blocking calcium entry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Memantine (Namenda) adverse effects

A

generally well tolerated;
CNS effects- dizziness, HA, confusion;
psychometric effects- agitation, delusions, and hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Memantine (Namenda) nursing considerations

A

don’t crush or chew ER preparations
monitor cognitive and functional outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Vecuronium (Norcuron) mechanism of action

A

competitively binds to nitotinic M receptors on the motor end plate to block activation by ACh, causes muscle relaxation and persists as long as medication is sufficient to prevent receptor occupation by ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Vecuronium (Norcuron) adverse effects

A

respiratory arrest and hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Vecuronium (Norcuron) nursing considerations

A

reversal agent is neostigmine;
use with caution in pts with MG;
doesn’t cross BBB- doesn’t effect LOC or perception of pain;
monitor pts on MV and promote comfort

33
Q

Succinylcholine (Anectine) mechanism of action

A

competitively binds to nicotinic M receptors on the motor end plate to block activation by ACh to produce state of constant depolarization; clinically proven to provide muscle relaxation during surgery, MV, ET intubation

34
Q

Succinylcholine (Anectine) adverse effects

A

prolonged apnea
malignant hyperthermia
hyperkalemia
post-op muscle pain

35
Q

Succinylcholine (Anectine) nursing considerations

A

use with caution in pts with MG;
unable to cross BBB- doesn’t effect LOC or perception of pain;
monitor pts on MV and promote comfort;
ice packs, cold IV saline, and IV dantrolene for malignant hyperthermia

36
Q

Lidocaine (Xylocaine) mechanism of action

A

stop axonal conduction by blocking sodium channels in the axonal membrane

37
Q

Lidocaine (Xylocaine) adverse affects

A

CNS depression and excitation;
CV suppression- bradycardia, heart block, decreased contractility, and cardiac arrest;
allergic reactions

38
Q

Lidocaine (Xylocaine) nursing considerations

A

injected form has higher risk of systemic effects
monitor for vasoconstriction s/s if used with epinephrine
monitor neurological and CV status with admin

39
Q

Nitrous Oxide mechanism of action

A

enhance transmission at inhibitory synapses and depress transmission at excitatory synapses through binding with the NMDA receptor

40
Q

Nitrous Oxide adverse effects

A

respiratory and cardiac depression;
malignant hyperthermia;
aspiration of gastric contents;
hepatotoxicity;
post-op N/V

41
Q

Nitrous Oxide nursing considerations

A

often used supplementally with other anesthetic agents;
monitor for adverse effects;
assess and treat post-op pain and N/V

42
Q

Midazolam (Versed) mechanism of action

A

enhance transmission at inhibitory synapses and depress transmission at excitatory synapses through activation of receptors for GABA

43
Q

Midazolam (Versed) adverse effects

A

respiratory depression,
hypotension,
cardiac arrest,

44
Q

Midazolam (Versed) nursing considerations

A

rapid onset and short durations = monitor sedation and mental status as it can change quickly;
slow injection administration to help minimize adverse effects;
monitor respiratory and CV status closely;
flumazenil is antidote for OD

45
Q

Propofol (Diprivan) mechanism of action

A

enhance transmission at inhibitory synapses and depresses transmission at excitatory synapses through activation of receptors for GABA

46
Q

Propofol (Diprivan) adverse effects

A

respiratory depression and hypotension
higher risk for bacterial infection
propofol injection syndrome- metabolic acidosis, renal failure, cardiac failure, and rhabdomyolysis
clinician abuse

47
Q

Propofol (Diprivan) nursing considerations

A

rapid onset and ultrashort durations = monitor sedation and mental status closely;
monitor respiratory and CV status closely;
monitor for s/s of propofol injection syndrome;
follow facility protocol on disposing of vials

48
Q

Ketamine (Ketalar) mechanism of action

A

enhance transmission at inhibitory synapses and depress transmission at excitatory synapses through activation of receptors for GABA

49
Q

Ketamine (Ketalar) adverse effects

A

respiratory depression and hypotension;
psychological reactions- hallucinations, disturbing dreams, and delirium;
potential for abuse

50
Q

Ketamine (Ketalar) nursing considerations

A

reduce risk for psychological reactions by pre-medicating with diazepam or midazolam
assess for prior psychiatric illness
frequently used in changing of burn dressing

51
Q

Epinephrine (Adrenalin/EpiPen) MOA

A

adrenergic agonist class medication with actions at b1, b2, a1, and a2 receptors to produce bronchodilation

52
Q

Epinephrine (Adrenalin/EpiPen) adverse effects

A

CV- hypertension, dysrhythmia, angina pectoris;
Necrosis;
IV line extravasation;
Hyperglycemia

53
Q

Epinephrine (Adrenalin/EpiPen) nursing considerations

A

continually monitor V/S and IV sites;
Increased insulin therapy needed for pts w/ existing diabetes;
Caution in high-risk patients;
numerous medication interactions

54
Q

Norepinephrine (Levophed) MOA

A

adrenergic agonist class medication with actions at b1, a1, and a2 to cause vessel constriction

55
Q

Norepinephrine (Levophed) adverse effects

A

altered heart rate and rhythm
chest pain
local necrosis

56
Q

Norepinephrine (Levophed) nursing considerations

A

monitor CV status
assess access sites and extremities for signs of ischemia

57
Q

Dopamine MOA

A

adrenergic agonist class medication with dose dependent effects ranging from dopamine receptors, b1 and a1 receptors; effects ranging from renal vasodilation to cardiac stimulation

58
Q

Dopamine adverse effects

A

CV- tachycardia, dysrhythmias, anginal pain;
necrosis and localized vasoconstriction

59
Q

Dopamine nursing considerations

A

monitor CV status;
monitor I/Os to monitor renal function;
stop infusion and administer phentolamine if extravasation occurs

60
Q

Albuterol (Ventolin) MOA

A

adrenergic agonist class medication with actions selective at b2 receptors only BUT it can sometimes effect b1 to cause bronchodilation for obstructive pulmonary conditions

61
Q

Albuterol (Ventolin) adverse effects

A

hyperglycemia in diabetic pts
tremors (due to inc. muscle contraction)

62
Q

Albuterol (Ventolin) nursing considerations

A

monitor for cardioselective activity from increased HR;
monitor glucose in pts with DM

63
Q

Albuterol (Ventolin) patient education

A

education on proper inhalation technique if used as a PRN SABA and assess home use

64
Q

Prazosin (Minipress) MOA

A

adrenergic antagonist medication with actions selective for a1 receptors for treatment for high BP in essential HTN

65
Q

Prazosin (Minipress) adverse effects

A

orthostatic hypotension,
reflex tachycardia,
nasal congestion,
inhibition for ejaculation,
sodium retention and increased blood volume

66
Q

Prazosin (Minipress) nursing considerations

A

obtain BP and HR prior to admin,
educate pts on changing positions after starting med,
can be administered with or without food,
monitor for higher risk of falls,

67
Q

Tamsulosin (Flomax) MOA

A

adrenergic antagonist class medication with actions selective for a1 receptors in the bladder neck for treatment of BPH

68
Q

Tamsulosin (Flomax) adverse efffects

A

headache and dizziness
abnormal ejaculation

69
Q

Tamsulosin (Flomax) nursing considerations

A

monitor BP
evaluate urinary habits to monitor for response

70
Q

b1 blockers

A

propranolol (Inderal) - 1st gen
metoprolol (Lopressor) - 2nd gen
carvedilol (Coreg) - 3rd gen

71
Q

beta blockers MOA

A

adrenergic antagonist class medication
1st gen: nonselective
2nd gen: cardioselective
3rd gen: vasodilating actions

72
Q

beta blocker adverse effects

A

b1: bradycardia, reduced CO, HF, AV heart block, reduced
cardiac excitation;
b2: bronchoconstriction, hypoglycemia;
bradycardia and respiratory distress in neonates

73
Q

beta blocker nursing considerations

A

monitor hear rhythm, BP, and HR prior to admin;
monitor for respiratory distress in pts with obstructive respiratory conditions and myocardial suppression-related HF

74
Q

beta blockers patient education

A

education on possible signs of hypoglycemia due to symptom masking

75
Q

Clonidine (Catapres) MOA

A

activates a2 receptors in the CNS to reduce sympathetic outflow to blood vessels and heart

76
Q

Clonidine (Catapres) adverse effects

A

drowsiness,
xerostomia,
rebound HTN,
potential for abuse,
potential for fetal harm

77
Q

Clonidine (Catapres) nursing considerations

A

monitor BP and HR prior to admin
assess for history of illicit drug and opioid abuse

78
Q

Clonidine (Catapres) patient education

A

educate on using gum, hard candy, and hydration to limit xerostomia
warn about rebound hypertension

79
Q

Mirabegron (Myrbetriq) nursing considerations

A

alternative agent for pts that cannot tolerate anticholinergic agents,
can be used with other anticholinergic agents for OAB,
stop med if angioedema occurs
monitor BP closely in pts with pre-existing HTN